Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB; Treatment of Osteoporosis with Parathyroid Hormone Study Group. Greenspan SL, et al. Ann Intern Med. 2007 Mar 6;146(5):326-39. doi: 10.7326/0003-4819-146-5-200703060-00005. Ann Intern Med. 2007. PMID: 17339618 Clinical Trial.
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A. Greenspan SL, et al. Ann Intern Med. 2002 Dec 3;137(11):875-83. doi: 10.7326/0003-4819-137-11-200212030-00008. Ann Intern Med. 2002. PMID: 12458987 Clinical Trial.
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.
Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr, Boone S, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Silverman S, Siris ES, Watts NB. Greenspan SL, et al. J Am Geriatr Soc. 2012 Mar;60(3):455-61. doi: 10.1111/j.1532-5415.2011.03854.x. Epub 2012 Feb 8. J Am Geriatr Soc. 2012. PMID: 22316070 Free PMC article.
Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis.
Black DM, Bilezikian JP, Greenspan SL, Wüster C, Muñoz-Torres M, Bone HG, Rosen CJ, Andersen HS, Hanley DA. Black DM, et al. Among authors: greenspan sl. Osteoporos Int. 2013 Apr;24(4):1503-11. doi: 10.1007/s00198-012-2098-3. Epub 2012 Aug 29. Osteoporos Int. 2013. PMID: 22930240 Free PMC article. Clinical Trial.
Obesity is not protective against fracture in postmenopausal women: GLOW.
Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Díez-Pérez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, Adachi JD, Rossini M, Lacroix AZ, Roux C, Sambrook PN, Siris ES; Glow Investigators. Compston JE, et al. Am J Med. 2011 Nov;124(11):1043-50. doi: 10.1016/j.amjmed.2011.06.013. Am J Med. 2011. PMID: 22017783 Free PMC article.
263 results